Stay up-to-date with the latest information from Quadriga
Press Releases
October 25, 2022
Quadriga BioSciences Announces Completion of Enrollment in Phase 1 Study of QBS72S for Solid Tumors
July 23, 2020
Quadriga Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
October 10, 2017
Quadriga Wins $2M Phase II SBIR Grant for the Treatment of Glioblastoma Multiforme